Barrett Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-102
Closed -$67K 330
2021
Q4
$67K Buy
102
+2
+2% +$1.26K ﹤0.01% 353
2021
Q3
$62K Hold
100
﹤0.01% 294
2021
Q2
$63K Hold
100
﹤0.01% 288
2021
Q1
$49K Hold
100
﹤0.01% 304
2020
Q4
$50K Hold
100
﹤0.01% 271
2020
Q3
$39K Hold
100
﹤0.01% 265
2020
Q2
$33K Sell
100
-25
-20% -$7.24K ﹤0.01% 275
2020
Q1
$30K Hold
125
﹤0.01% 253
2019
Q4
$33K Hold
125
﹤0.01% 275
2019
Q3
$34K Hold
125
﹤0.01% 258
2019
Q2
$34K Hold
125
﹤0.01% 257
2019
Q1
$28K Hold
125
﹤0.01% 271
2018
Q4
$23K Hold
125
﹤0.01% 285
2018
Q3
$31K Sell
125
-25
-17% -$6.07K ﹤0.01% 275
2018
Q2
$33K Hold
150
﹤0.01% 274
2018
Q1
$29K Sell
150
-50
-25% -$9.23K ﹤0.01% 281
2017
Q4
$31K Sell
200
-50
-20% -$7.87K ﹤0.01% 285
2017
Q3
$39K Hold
250
﹤0.01% 251
2017
Q2
$40K Hold
250
﹤0.01% 260
2017
Q1
$39K Hold
250
﹤0.01% 243
2016
Q4
$29K Hold
250
﹤0.01% 262
2016
Q3
$28K Hold
250
﹤0.01% 248
2016
Q2
$23K Hold
250
﹤0.01% 254
2016
Q1
$20K Hold
250
﹤0.01% 263
2015
Q4
$18K Hold
250
﹤0.01% 254
2015
Q3
$19K Hold
250
﹤0.01% 243
2015
Q2
$16K Buy
+250
New +$17.3K ﹤0.01% 265

Other funds holding IDXX

Barrett Asset Management's IDXX Position: Q1 2022 in Review

Barrett Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 102 shares — an estimated $67K sold.

Barrett Asset Management first reported a position in IDXX in Q2 2015 and held it in 27 quarters. The position peaked at $67K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Barrett Asset Management reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • Barrett Asset Management sold 102 Idexx Laboratories shares in Q1 2022, an estimated $67K.
  • Barrett Asset Management first reported a position in Idexx Laboratories in Q2 2015 and held it in 27 quarters.
  • Barrett Asset Management's Idexx Laboratories position peaked at $67K in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.